This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2005 Dec;44(12):1064-5.

doi: 10.1111/j.1365-4632.2004.02597.x.

Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis

Zahra Moosavi, Abdolhamid Nakhli, Sima Rassaii

PMID: 16409282
DOI: 10.1111/j.1365-4632.2004.02597.x

Clinical Trial

Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis

Zahra Moosavi et al. Int J Dermatol. 2005 Dec.

. 2005 Dec;44(12):1064-5.

doi: 10.1111/j.1365-4632.2004.02597.x.

Authors

Zahra Moosavi, Abdolhamid Nakhli, Sima Rassaii

PMID: 16409282
DOI: 10.1111/j.1365-4632.2004.02597.x

No abstract available

PubMed Disclaimer

Similar articles

Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B, Abbaszadeh B, Khamesipour A. Shazad B, et al. Eur J Dermatol. 2005 Mar-Apr;15(2):85-7. Eur J Dermatol. 2005. PMID: 15757817 Clinical Trial.
Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
Salmanpour R, Razmavar MR, Abtahi N. Salmanpour R, et al. Int J Dermatol. 2006 Sep;45(9):1115-6. doi: 10.1111/j.1365-4632.2006.02822.x. Int J Dermatol. 2006. PMID: 16961529 Clinical Trial. No abstract available.
Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
Faghihi G, Tavakoli-kia R. Faghihi G, et al. Clin Exp Dermatol. 2003 Jan;28(1):13-6. doi: 10.1046/j.1365-2230.2003.01169.x. Clin Exp Dermatol. 2003. PMID: 12558620 Clinical Trial.
[Cutaneous leishmaniasis].
Enk CD, Gardlo K, Hochberg M, Ingber A, Ruzicka T. Enk CD, et al. Hautarzt. 2003 Jun;54(6):506-12. doi: 10.1007/s00105-003-0530-5. Epub 2003 Apr 18. Hautarzt. 2003. PMID: 12759734 Review. German.
Treatment of cutaneous leishmaniasis in travelers 2009.
Blum JA, Hatz CF. Blum JA, et al. J Travel Med. 2009 Mar-Apr;16(2):123-31. doi: 10.1111/j.1708-8305.2008.00286.x. J Travel Med. 2009. PMID: 19335813 Review. No abstract available.

See all similar articles

Cited by

Effectiveness of Paromomycin on Cutaneous Leishmaniasis in Iran: A Systematic Review and Meta-Analysis.
Moradzadeh R, Golmohammadi P, Ashraf H, Nadrian H, Fakoorziba MR. Moradzadeh R, et al. Iran J Med Sci. 2019 May;44(3):185-195. Iran J Med Sci. 2019. PMID: 31182884 Free PMC article. Review.
Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial.
Farajzadeh S, Heshmatkhah A, Vares B, Mohebbi E, Mohebbi A, Aflatoonian M, Eybpoosh S, Sharifi I, Aflatoonian MR, Shamsi Meymandi S, Fekri AR, Mostafavi M. Farajzadeh S, et al. J Parasit Dis. 2016 Dec;40(4):1159-1164. doi: 10.1007/s12639-014-0641-1. Epub 2015 Jan 22. J Parasit Dis. 2016. PMID: 27876906 Free PMC article.
Evaluation of the Interventional Approaches in the Management of Cutaneous Leishmaniasis in Jazan: An Observational Study.
Makeen HA, Buraik MA, Menachery SJ, Alattas KM, Meraya AM. Makeen HA, et al. Ann Dermatol. 2018 Oct;30(5):575-580. doi: 10.5021/ad.2018.30.5.575. Epub 2018 Aug 28. Ann Dermatol. 2018. PMID: 33911481 Free PMC article.
Comparison of Intralesional Sodium Stibogluconate versus Intralesional Meglumine Antimoniate for the Treatment of Leishmania major Cutaneous Leishmaniasis.
Solomon M, Ollech A, Pavlotsky F, Barzilai A, Schwartz E, Baum S, Astman N. Solomon M, et al. Acta Derm Venereol. 2024 Apr 29;104:adv35089. doi: 10.2340/actadv.v104.35089. Acta Derm Venereol. 2024. PMID: 38682801 Free PMC article.
Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J, Monge-Maillo B, Pinart M, Lopez Pereira P, Reveiz L, Garcia-Carrasco E, Campuzano Cuadrado P, Royuela A, Mendez Roman I, López-Vélez R. Heras-Mosteiro J, et al. Cochrane Database Syst Rev. 2017 Dec 1;12(12):CD005067. doi: 10.1002/14651858.CD005067.pub5. Cochrane Database Syst Rev. 2017. PMID: 29192424 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley